Modine Manufacturing Company vs Recursion Pharmaceuticals Inc — how do they compare? Modine Manufacturing Company trades at $245.92 (market cap $12.18B), while Recursion Pharmaceuticals Inc trades at $3.07 (market cap $1.53B). The key difference: Modine Manufacturing Company is far larger — about 8× Recursion Pharmaceuticals Inc's market cap, and Modine Manufacturing Company is trading nearer its 52-week high, Recursion Pharmaceuticals Inc nearer its low. Which is the better fit depends on your goals.
| MOD | RXRX | |
|---|---|---|
Market Cap | $12.18B | $1.53B |
Sector | Technology | Health |
52-Week High | $306.89 | $6.79 |
52-Week Low | $93.71 | $2.84 |
Enterprise Value | $12.54B | $946.50M |
Signals from Pluang's Aura AI — not financial advice
MOD trades at $227.88, down 0.64% today, with a bearish technical signal from moving averages. The company reported strong earnings beats in recent quarters, with Q1 2026 EPS of $1.71 exceeding expectations. Revenue reached $2.58B in 2025, though net income margin is modest at 3.82%. Recent news includes institutional buying and executive appointments, while technical support sits near $221.
Analyst consensus is bullish with a $328.80 price target, but high P/E of 101.48 suggests premium valuation. Risks include margin pressure from supply chain challenges and competitive threats in data center cooling. The stock offers growth potential if margin expansion continues, but investors face volatility from technical weakness and execution risks.
No Aura AI signal available yet.
Trailing returns across standard periods
Modine Manufacturing Company is a global leader in thermal management technology and solutions. The company engineers, manufactures, and markets heat transfer products for a wide range of applications across the automotive, commercial, industrial, and HVAC (heating, ventilation, and air conditioning) markets. Modine's products include engine cooling systems, heat exchangers, and ventilation systems, providing critical thermal solutions for vehicles, data centers, and various equipment worldwide.
Read more on MOD →Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company leveraging artificial intelligence (AI) and machine learning to industrialize drug discovery. The company's unique approach combines one of the world's largest biological and chemical datasets with automated wet-lab and computational systems to map human biology and identify potential therapeutic candidates across a range of diseases, including oncology and rare diseases. Recursion aims to accelerate the traditionally slow and expensive process of drug development.
Read more on RXRX →